Stock 000403 PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Pacific Shuanglin Bio-pharmacy Co., LTD

Equities

000403

CNE000000F14

Pharmaceuticals

End-of-day quote Shenzhen S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
29.29 CNY -1.61% Intraday chart for Pacific Shuanglin Bio-pharmacy Co., LTD -1.15% +7.53%
04-26 Pacific Shuanglin Bio-pharmacy Co., LTD Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-15 Pacific Shuanglin Bio-pharmacy's 2023 Profit Jumps 4% Despite Lower Revenue; Shares Rise 4% MT

Business Summary

Pacific Shuanglin Bio pharmacy Co Ltd, formerly Southern Shuanglin Bio-pharmacy Co Ltd, formerly Zhenxing Biopharmaceutical & Chemical Co., Ltd., is a China-based company mainly engaged in the research, development, production and sales of blood products. The Company's main products are human albumin, intravenous immunoglobulin (pH4), human immunoglobulin, hepatitis B human immunoglobulin, tetanus immunoglobulin and rabies immunoglobulin. The Company mainly operates its business in the domestic market.

Number of employees: 2,426

Sales per Business

CNY in Million2022Weight2023Weight Delta
Blood
99.8 %
2,396 99.6 % 2,324 99.8 % -2.97%
Others
0.1 %
10 0.4 % 3 0.1 % -65.97%
Matrix Body
0.0 %
- - 1 0.0 % -

Sales per region

CNY in Million2022Weight2023Weight Delta
China
98.4 %
2,292 95.3 % 2,291 98.4 % -0.04%
Abroad
1.6 %
113 4.7 % 37 1.6 % -66.90%

Managers

Managers TitleAgeSince
Ye Hong Wang DFI
 Director of Finance/CFO 33 25/03/21
Xiao Ying Huang BRD
 Director/Board Member 50 24/10/23
Yu Lin Zhao SEC
 Corporate Secretary 37 20/05/19

Members of the board

Members of the board TitleAgeSince
Jun Yin BRD
 Director/Board Member 69 24/10/23
Jin Gang Zhang BRD
 Director/Board Member 61 12-10
Shao Lan Fu CHM
 Chairman 82 12-10
Zuo Jun Dong BRD
 Director/Board Member 54 22/03/21
Xiao Ying Huang BRD
 Director/Board Member 50 24/10/23

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 737,495,118 374,703,476 ( 50.81 %) 0 50.81 %

Shareholders

NameEquities%Valuation
Gongqingcheng Shengbang Yinghao Investment Partnership LP
24.05 %
153,752,812 24.05 % 599 M ¥
Shao Lan Fu
10.33 %
66,073,428 10.33 % 257 M ¥
KAISA GROUP HOLDINGS LTD.
5.351 %
34,217,201 5.351 % 133 M ¥
Ningbo Guojun Yuanhong Investment Management Co. Ltd.
3.411 %
21,808,400 3.411 % 85 M ¥
Hengqin Guangjin Beautiful Fund Management Co., Ltd.
2.127 %
13,600,000 2.127 % 53 M ¥
Zhejiang United Investment Group
1.777 %
11,362,263 1.777 % 44 M ¥
Dajia Life Insurance Co. Ltd.
1.648 %
10,535,974 1.648 % 41 M ¥
China Cinda Asset Management Co., Ltd. (Investment Company)
1.376 %
8,800,000 1.376 % 34 M ¥
Tianjin Honghan Technology Ltd.
1.276 %
8,157,212 1.276 % 32 M ¥
Jing Rui Zhang
1.253 %
8,014,584 1.253 % 31 M ¥
NameEquities%Valuation
Shao Lan Fu
27.77 %
25,824,477 27.77 % 101 M ¥
Feng Yang
4.309 %
4,007,293 4.309 % 16 M ¥
Li Yang
4.309 %
4,007,293 4.309 % 16 M ¥
Zhejiang Minying Enterprise Joint Investment Co. Ltd.
4.072 %
3,787,421 4.072 % 15 M ¥
Jing Rui Zhang
2.873 %
2,671,531 2.873 % 10 M ¥
Hua Gang Yuan
0.0448 %
41,686 0.0448 % 162 304 ¥
Ling Mou Huang
0.0448 %
41,686 0.0448 % 162 304 ¥
Di Wu
0.0231 %
21,469 0.0231 % 83 589 ¥
Bin Yang
0.0161 %
14,964 0.0161 % 58 262 ¥
Yu Lin Zhao
0.0161 %
14,964 0.0161 % 58 262 ¥

Holdings

NameEquities%Valuation
PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD
0.15%
 988,501 0.15% 3,848,719 $

Company contact information

Pacific Shuanglin Bio-pharmacy Co., Ltd.

1, Xinfeng East Road Donghai Island, Dongjian Town

524072, Zhanjiang

+

http://www.slbiop.com
address Pacific Shuanglin Bio-pharmacy Co., LTD(000403)

Sector

Healthcare
Pharmaceuticals & Medical Research
Pharmaceuticals
Pharmaceuticals
Biopharmaceuticals

Sales per Business

Sales per region

Ratings for Pacific Shuanglin Bio-pharmacy Co., LTD

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
29.29 CNY
Average target price
30 CNY
Spread / Average Target
+2.42%
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Biopharmaceuticals

1st Jan change Capi.
PACIFIC SHUANGLIN BIO-PHARMACY CO., LTD Stock Pacific Shuanglin Bio-pharmacy Co., LTD
+7.53% 2.96B
CSL LIMITED Stock CSL Limited
-3.93% 86.16B
SAMSUNG BIOLOGICS CO.,LTD. Stock Samsung Biologics Co.,Ltd.
+2.76% 40.17B
BIOGEN INC. Stock Biogen Inc.
-17.49% 31.47B
UCB Stock UCB
+54.44% 25.24B
BIOMARIN PHARMACEUTICAL INC. Stock BioMarin Pharmaceutical Inc.
-13.13% 15.82B
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. Stock Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.
-9.12% 11.96B
INCYTE CORPORATION Stock Incyte Corporation
-15.45% 11.89B
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD. Stock Chongqing Zhifei Biological Products Co., Ltd.
-42.56% 11.61B
SWEDISH ORPHAN BIOVITRUM AB Stock Swedish Orphan Biovitrum AB
+4.87% 8.84B
Biopharmaceuticals
  1. Stock Market
  2. Equities
  3. 000403 Stock
  4. Company Pacific Shuanglin Bio-pharmacy Co., LTD